HK1014874A1 - Novel formulation for peptide release. - Google Patents

Novel formulation for peptide release.

Info

Publication number
HK1014874A1
HK1014874A1 HK99100086A HK99100086A HK1014874A1 HK 1014874 A1 HK1014874 A1 HK 1014874A1 HK 99100086 A HK99100086 A HK 99100086A HK 99100086 A HK99100086 A HK 99100086A HK 1014874 A1 HK1014874 A1 HK 1014874A1
Authority
HK
Hong Kong
Prior art keywords
formulation
novel formulation
peptide release
deslorelin
mug
Prior art date
Application number
HK99100086A
Other languages
English (en)
Inventor
John Desmond Walsh
Timothy Elliot Trigg
Original Assignee
Peptech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptech Ltd filed Critical Peptech Ltd
Publication of HK1014874A1 publication Critical patent/HK1014874A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK99100086A 1995-06-20 1999-01-08 Novel formulation for peptide release. HK1014874A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN3667A AUPN366795A0 (en) 1995-06-20 1995-06-20 Formulation for preventing reproductive function
PCT/AU1996/000370 WO1997000693A1 (en) 1995-06-20 1996-06-20 Novel formulation for peptide release

Publications (1)

Publication Number Publication Date
HK1014874A1 true HK1014874A1 (en) 1999-10-08

Family

ID=3788008

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99100086A HK1014874A1 (en) 1995-06-20 1999-01-08 Novel formulation for peptide release.

Country Status (17)

Country Link
US (2) US5925619A (xx)
EP (1) EP0871467B1 (xx)
JP (1) JP4016133B2 (xx)
CN (1) CN1145496C (xx)
AT (1) ATE223726T1 (xx)
AU (2) AUPN366795A0 (xx)
CA (1) CA2225796C (xx)
DE (2) DE69623652T2 (xx)
DK (1) DK0871467T3 (xx)
ES (1) ES2182983T3 (xx)
FR (1) FR08C0001I2 (xx)
HK (1) HK1014874A1 (xx)
NL (1) NL300330I2 (xx)
NZ (1) NZ309697A (xx)
PT (1) PT871467E (xx)
SI (1) SI0871467T1 (xx)
WO (1) WO1997000693A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN366795A0 (en) * 1995-06-20 1995-07-13 Peptide Technology Limited Formulation for preventing reproductive function
EP1007080B1 (en) 1996-08-30 2007-04-18 Peptech Limited Formulation for the sustained release of peptide agonists and analogues of GnRH
BR9912275A (pt) * 1998-07-20 2001-04-17 Peptech Ltd Formulação de bioimplante
US8052982B2 (en) * 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
US6211221B1 (en) * 1999-04-05 2001-04-03 Johnny W. Peterson Dietary supplement containing histidine for alleviating dysmenorrhea, endometriosis, and pre-term labor
AU2001295359A1 (en) * 2000-10-30 2002-05-15 University Of Zurich GnRH analogues for treatment of urinary incontinence
GB0221539D0 (en) * 2002-09-17 2002-10-23 Medical Res Council Methods of treatment
WO2005067889A1 (en) * 2003-12-30 2005-07-28 Durect Corporation Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of active agents, preferably a gnrh
US20080254086A1 (en) * 2004-12-23 2008-10-16 Brown James E Controlled Release Compositions
JP2010539010A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としてのデスロレリンおよびマストパランの使用
DE102008015104A1 (de) 2008-03-19 2009-09-24 Basf Coatings Ag Beschichtungszusammensetzung, Verfahren zu ihrer Herstellung, ihre Verwendung und mit ihr beschichtete Substrate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS563846B2 (xx) * 1972-10-12 1981-01-27
US4218439A (en) * 1977-07-14 1980-08-19 The Salk Institute For Biological Studies Peptide which inhibits gonadal function
US4256737A (en) * 1979-06-11 1981-03-17 Syntex (U.S.A.) Inc. Long acting depot injectable formulations for LH-RH analogues
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
DE3777721D1 (de) * 1986-08-11 1992-04-30 American Cyanamid Co Zusammensetzungen zur parenteralen verabreichung und deren verwendung.
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
US5470582A (en) * 1992-02-07 1995-11-28 Syntex (U.S.A.) Inc. Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
AUPN366795A0 (en) * 1995-06-20 1995-07-13 Peptide Technology Limited Formulation for preventing reproductive function

Also Published As

Publication number Publication date
EP0871467A4 (en) 2000-07-05
CN1145496C (zh) 2004-04-14
DE122008000004I2 (de) 2009-08-06
US6211152B1 (en) 2001-04-03
US5925619A (en) 1999-07-20
AUPN366795A0 (en) 1995-07-13
JP2001521482A (ja) 2001-11-06
EP0871467A1 (en) 1998-10-21
ES2182983T3 (es) 2003-03-16
CA2225796A1 (en) 1997-01-09
SI0871467T1 (en) 2003-08-31
FR08C0001I1 (xx) 2008-03-21
NZ309697A (en) 1999-11-29
EP0871467B1 (en) 2002-09-11
FR08C0001I2 (xx) 2009-11-20
JP4016133B2 (ja) 2007-12-05
DE69623652D1 (de) 2002-10-17
AU701837B2 (en) 1999-02-04
AU5992796A (en) 1997-01-22
PT871467E (pt) 2002-12-31
NL300330I1 (nl) 2008-03-03
DK0871467T3 (da) 2002-12-23
WO1997000693A1 (en) 1997-01-09
DE122008000004I1 (de) 2008-04-17
DE69623652T2 (de) 2003-05-28
CN1188414A (zh) 1998-07-22
NL300330I2 (nl) 2008-04-01
ATE223726T1 (de) 2002-09-15
CA2225796C (en) 2011-09-20

Similar Documents

Publication Publication Date Title
FR08C0001I2 (xx)
AU4718496A (en) Use of aerogels in agriculture
MY113488A (en) Compounds with growth hormone releasing properties
AU560829B2 (en) Continuous release pharmaceutical compositions
IL102591A (en) Compositions for the sustained and controlled release of peptide medicaments and their preparation
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
IL123505A0 (en) Sustained release matrix for high-dose insoluble drugs
IL111734A0 (en) Compositions for the preparation of in vivo therapeutic products
GR3026338T3 (en) High release solid preparation, preparation and use thereof
EP1178988A4 (en) THERAPEUTIC COMPOUNDS AND METHODS
PL313223A1 (en) Nigella sativa as a therapeutic agent
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
EP0663835A1 (en) USE OF PARATHORMONE, ITS BIOLOGICALLY ACTIVE FRAGMENTS AND RELATED PEPTIDES FOR THE TREATMENT OF PREGNANCY PROBLEMS.
IL107153A (en) Pharmaceutical compositions for preventing insulin-dependent diabetes mellitus comprising IL10 and method for their manufacture
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
HUP9802536A3 (en) Pharmaceutical compositions containing 1,2,4-benzotriazine 1,4-dioxide and use thereof for the preparation of pharmaceutical compositions treating cancer
OA09771A (en) Asphodelus composition for increasing white blood cell count.
BG51699A1 (en) Stimulating fertility agent
UA30723A (uk) Спосіб лікування аутоімунних захворювань
UA7163A (uk) Спосіб відновлення ушкоджених тканин людини чи тварини
MX9800697A (es) Uso de glicosidos de calendula para el tratamiento de psoriasis.

Legal Events

Date Code Title Description
CHPA Change of a particular in the register (except of change of ownership)
PE Patent expired

Effective date: 20160619